Cargando…

Services provided for axial spondyloarthritis patients by rheumatologists in India: a survey

OBJECTIVE: We sought to evaluate the current knowledge and attitudes of Indian rheumatologists concerning axial spondyloarthritis (axSpA) with respect to recent terminology for diagnosis, management strategies and additional services. METHODS: The survey was designed for spondyloarthritis care given...

Descripción completa

Detalles Bibliográficos
Autores principales: Pathak, Himanshu, Ajmani, Sajal, Kumar, Ashok, Misra, Ramnath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519189/
https://www.ncbi.nlm.nih.gov/pubmed/34661048
http://dx.doi.org/10.1093/rap/rkab048
_version_ 1784584398811693056
author Pathak, Himanshu
Ajmani, Sajal
Kumar, Ashok
Misra, Ramnath
author_facet Pathak, Himanshu
Ajmani, Sajal
Kumar, Ashok
Misra, Ramnath
author_sort Pathak, Himanshu
collection PubMed
description OBJECTIVE: We sought to evaluate the current knowledge and attitudes of Indian rheumatologists concerning axial spondyloarthritis (axSpA) with respect to recent terminology for diagnosis, management strategies and additional services. METHODS: The survey was designed for spondyloarthritis care given by rheumatologists in the Indian health-care context. The structured survey consisted of a combination of multiple-choice and open-ended questions. An anonymous Web-based questionnaire was sent to 710 members of the Indian Rheumatology Association, and descriptive analysis of responses was done. RESULTS: The survey respondents were from government and private health-care facilities and gave a response rate of 19% (133 of 710). About 49% of respondents were using the terminology axSpA for a new diagnosis of spondyloarthritis (SpA). BASDAI was used routinely as the main disease monitoring tool by most respondents (76.2%). Same-day MRI was available to 42.9% (51 of 119) respondents. Selective cyclooxygenase-2 inhibitors were the preferred first NSAID for 50% of respondents, and SSZ was the most preferred DMARD for peripheral arthritis. Financial constraints were the most common factor that affected the initiation of biologics and also the most common reason for stopping biological therapies. Nearly 65% (80 of 122) of respondents did not have a multidisciplinary team available in clinical practice, and only 15% of respondents had access to patient support groups. CONCLUSION: For a new diagnosis, the terminology of axSpA is not fully accepted by Indian rheumatologists. The axSpA management given by Indian rheumatologists is in agreement with recent guidelines, however, there is a significant lack of accessibility to multidisciplinary care and patient support groups in India.
format Online
Article
Text
id pubmed-8519189
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-85191892021-10-15 Services provided for axial spondyloarthritis patients by rheumatologists in India: a survey Pathak, Himanshu Ajmani, Sajal Kumar, Ashok Misra, Ramnath Rheumatol Adv Pract Concise Report OBJECTIVE: We sought to evaluate the current knowledge and attitudes of Indian rheumatologists concerning axial spondyloarthritis (axSpA) with respect to recent terminology for diagnosis, management strategies and additional services. METHODS: The survey was designed for spondyloarthritis care given by rheumatologists in the Indian health-care context. The structured survey consisted of a combination of multiple-choice and open-ended questions. An anonymous Web-based questionnaire was sent to 710 members of the Indian Rheumatology Association, and descriptive analysis of responses was done. RESULTS: The survey respondents were from government and private health-care facilities and gave a response rate of 19% (133 of 710). About 49% of respondents were using the terminology axSpA for a new diagnosis of spondyloarthritis (SpA). BASDAI was used routinely as the main disease monitoring tool by most respondents (76.2%). Same-day MRI was available to 42.9% (51 of 119) respondents. Selective cyclooxygenase-2 inhibitors were the preferred first NSAID for 50% of respondents, and SSZ was the most preferred DMARD for peripheral arthritis. Financial constraints were the most common factor that affected the initiation of biologics and also the most common reason for stopping biological therapies. Nearly 65% (80 of 122) of respondents did not have a multidisciplinary team available in clinical practice, and only 15% of respondents had access to patient support groups. CONCLUSION: For a new diagnosis, the terminology of axSpA is not fully accepted by Indian rheumatologists. The axSpA management given by Indian rheumatologists is in agreement with recent guidelines, however, there is a significant lack of accessibility to multidisciplinary care and patient support groups in India. Oxford University Press 2021-08-16 /pmc/articles/PMC8519189/ /pubmed/34661048 http://dx.doi.org/10.1093/rap/rkab048 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Concise Report
Pathak, Himanshu
Ajmani, Sajal
Kumar, Ashok
Misra, Ramnath
Services provided for axial spondyloarthritis patients by rheumatologists in India: a survey
title Services provided for axial spondyloarthritis patients by rheumatologists in India: a survey
title_full Services provided for axial spondyloarthritis patients by rheumatologists in India: a survey
title_fullStr Services provided for axial spondyloarthritis patients by rheumatologists in India: a survey
title_full_unstemmed Services provided for axial spondyloarthritis patients by rheumatologists in India: a survey
title_short Services provided for axial spondyloarthritis patients by rheumatologists in India: a survey
title_sort services provided for axial spondyloarthritis patients by rheumatologists in india: a survey
topic Concise Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519189/
https://www.ncbi.nlm.nih.gov/pubmed/34661048
http://dx.doi.org/10.1093/rap/rkab048
work_keys_str_mv AT pathakhimanshu servicesprovidedforaxialspondyloarthritispatientsbyrheumatologistsinindiaasurvey
AT ajmanisajal servicesprovidedforaxialspondyloarthritispatientsbyrheumatologistsinindiaasurvey
AT kumarashok servicesprovidedforaxialspondyloarthritispatientsbyrheumatologistsinindiaasurvey
AT misraramnath servicesprovidedforaxialspondyloarthritispatientsbyrheumatologistsinindiaasurvey